Cardiology Fiesta 2018
Avatar

Stem Cell Therapy Improves Outcomes in Severe Heart Failure

By Cardiology Fiesta 2018 FEATURING Timothy Henry
By Cardiology Fiesta 2018 FEATURING Timothy Henry
223 views
November 28, 2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
NYU Langone

Advanced Heart Failure Cases and Controversies

Fri, May 10, 2024
Scripps Health

Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shoc…

Fri, Apr 26, 2024
See 1 other
Stanford Medicine

5th Annual Conference on Disability in Healthcare and Medicine

Sat, Apr 27, 2024
The Texas Heart Institute

Perfusion Conference 2024

Fri, Jun 7, 2024
See 3 others
UPMC

UPMC Hamot 2024 Cardiovascular Update

Fri, May 10, 2024
See 1 other
Cardiometabolic Health Congress (CMHC)

19th Annual Congress

Thu, Oct 17, 2024
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Precision Cardiovascular Care 2024: Transitioning Care from Phenotyp…

Fri, May 3, 2024
Venous Symposium

Venous Symposium 2024

Wed, May 8, 2024
American Academy of Anti-Aging Medicine

32nd Annual Spring Congress: The Metabolic Crisis

Fri, May 3, 2024
American Society of Nuclear Cardiology

Cardiac PET Intensive Virtual Workshop

Sat, Jun 1, 2024
See 1 other
Controversies in Interventional Cardiovascular Therapies - CICT 2024

Controversies in Interventional Cardiovascular Therapies - CICT 2024

Fri, Jul 26, 2024
The American Society for Preventive Cardiology

ASPC 2024 Congress on CVD Prevention

Fri, Aug 2, 2024
Didactic Presentations

30th Annual San Diego Heart Failure Symposium: Advances in the Recog…

Fri, Jul 19, 2024
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
07:19
CVRx | Barostim

Considering Quality of Life as Part of Patient Selection for Heart F…

Feat. L. Grazette
34:18
Scripps Health

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Feat. A. Kuo
12:50
AVA at Your Fingertips

Lessons Learned From Trials of Implementation: The CLABSI Section of…

Feat. V. Chopra
84:17
Jefferson Health

2022 Heart Failure Guidelines Review

Feat. D. Haas
28:48
MUSC Cardiology

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

Feat. S. Litwin
20:59
Mary E. Money

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

35:06
The New Orleans Conference

What Is Truly Informed Consent and Should The Perfusionist Get His/H…

27:52
Top Ten Topics in Clinical Cardiology 2023

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Feat. S. Pinney
22:48
Scripps Health

Heart Failure with Preserved Ejection Fraction: New Treatments

Feat. R. C. Mohan